Bubs Australia Ltd. · ASX:BUB
Bubs Australia — Citi's 13th Annual Australia & New Zealand Investment Conference 2021
20 slides from Bubs Australia's conference presentation, Oct 13, 2021
Slide 1: Turnaround to Growth
For personal use only TURNAROUND TO GROWTH Citi’s 13th Annual Australia & New Zealand Investment Conference 2021 Presented on 13th October 2021 Jennifer Hawkins Bubs Global Brand Ambassador
Slide 2: For personal use only
For personal use only
Slide 3: Vision & Values
VISION & VALUES For personal use only Creating new generations of happy & healthy GOODNESS VERY BEST We believe in wholesome, We believe in being thorough healthy food and a positive and uncompromising, sticking approach to life. to our ethics no matter what. HONESTY PLAYFULNESS We believe in 100% W
Slide 4: Q1 FY22 Financial Highlights
Q1 FY22 FINANCIAL REVIEW Q1 FY22 FINANCIAL HIGHLIGHTS $18.5m For personal use only Turnaround to accelerated growth across core markets and products, Group Gross Revenue1 with robust balance sheet and positive quarterly cashflow. +96% pcp +124% +35% Total Bubs® Infant Formula Scan sales value growth
Slide 5: Rebuild to Return to Accelerated Growth
Q1 FY22 FINANCIAL REVIEW REBUILD TO RETURN TO ACCELERATED GROWTH For personal use only Business growth strategy reflects transformation of business in post-Covid era. +96% pcp +45% QOQ GROUP QUARTERLY GROSS REVENUE¹ 25 Growth strategy Daigou channel turnaround Lockdown Pantry Stocking collapse due t
Slide 6: Export Focus: Market Diversification
Q1 FY22 FINANCIAL REVIEW EXPORT FOCUS: MARKET DIVERSIFICATION 2 For personal use only Global expansion strategy continues with advances in China Channels and new markets across SE Asia and USA. GROSS REVENUE1 CONTRIBUTION (%) Domestic home base continues to outperform 100 2 9 • Bubs domestic retail
Slide 7: Expanding Product Mix
Q1 FY22 FINANCIAL REVIEW EXPANDING PRODUCT MIX For personal use only Focus on Bubs Infant Formula as key profit margin driver, optimising milk pool utilisation and building B2B Industrial offering. PRODUCT PORTFOLIO GROSS REVENUE¹ CONTRIBUTION (%) HIGH GROWTH IN CORE PRODUCT SEGMENTS BUBS ADULT GOAT
Slide 8: Strategic Outcomes
For personal use only OUTCOMES STRATEGIC
Slide 9: Turnaround to Accelerated Growth
Q1 FY22 FINANCIAL REVIEW TURNAROUND TO ACCELERATED GROWTH For personal use only Responding to rapidly changing market dynamics, Bubs revamped business strategy was successful in returning the business to high growth during the quarter, overcoming COVID-19 disruption and challenging macro environment
Slide 10: FY22 Strategic Focus: Sales Channels
STRATEGIC OUTCOMES FY22 STRATEGIC FOCUS: 4 SALES CHANNELS We have continued to build our market access strategies around 4 strategic sales channels that are complementary to For personal use only unlock value. Each business unit has distinctive features and different opportunities for sustained prof
Slide 11: Domestic: Lead Challenger Brand
STRATEGIC OUTCOMES DOMESTIC: LEAD CHALLENGER BRAND For personal use only Bubs Australia is the fastest growing Infant Formula manufacturer1 with continued sales volume growth and market share gains. #2 GOAT BRAND² #2 ORGANIC COW BRAND² Coles Coles Woolworths Woolworths Chemist Warehouse Chemist Ware
Slide 12: China: All Channels in High Growth
STRATEGIC OUTCOMES CHINA: ALL CHANNELS IN HIGH GROWTH For personal use only 360◦ China1 Channel Strategy with transformed Daigou e-Commerce peer-endorsement, plus growing CBEC and O2O brand awareness and new user recruitment efficiency, bringing Bubs closer to our end consumers. CORPORATE DAIGOU CHA
Slide 13: Daigou 2.0 Re-routing Product Post COVID-19
STRATEGIC OUTCOMES DAIGOU 2.0 RE-ROUTING PRODUCT POST COVID-19 For personal use only Daigou Channel rapidly evolving towards social e-Commerce with bulk freight shipped directly to China bonded warehouses. Consumer demand for Bubs® products has remained strong throughout the pandemic and continues t
Slide 14: China: Building Offline-to-Online (O2O) Channel
STRATEGIC OUTCOMES CHINA: BUILDING OFFLINE-TO-ONLINE (O2O) CHANNEL For personal use only Expanding coverage in physical Mother & Baby stores and supermarkets with display of empty English label tins to enable interface with store professional staff and physical interaction with Bubs product. BUBS NO
Slide 15: International: Strategic Focus on Market Expansion
STRATEGIC OUTCOMES INTERNATIONAL: STRATEGIC FOCUS ON MARKET EXPANSION For personal use only Bubs® Infant Formula export sales to markets outside of China were up 154% pcp in Q1 FY21. MALAYSIA SINGAPORE USA Increased distribution in Q1 with new ranging Continued month-on-month sales Established local
Slide 16: B2B: Deloraine Dairy Solutions
STRATEGIC OUTCOMES B2B: DELORAINE DAIRY SOLUTIONS For personal use only Renewed strategic focus on B2B to leverage existing expertise and organisational capability, as a sign of a mature vertically integrated business of scale. Provides resilience, diversification of customer base and efficiencies a
Slide 17: Summary
For personal use only SUMMARY 17
Slide 18: Q1 FY22 Summary
SUMMARY Q1 FY22 SUMMARY For personal use only Our ‘Turnaround to Growth’ has commenced, with new business growth strategy tailored to transform our China business, increased international diversification and renewed B2B focus. • Q1 FY22 +96% pcp and +45% QoQ gross revenue¹ turnaround demonstrates si
Slide 19: Disclaimer
DISCLAIMER For personal use only DISCLAIMER This investor presentation (Presentation) is dated 13 October2021 and has been prepared by Bubs Australia Limited (ACN 060 094 742) (Bubs or the Company). The material in this Presentation is general background information about Bubs’ activities current at
Slide 20: For personal use only
For personal use only
Bubs Australia — Citi's 13th Annual Australia & New Zealand Investment Conference 2021 on 6ix